Effects of adjuvant treatment on cognitive function in women with early breast cancer

European Journal of Oncology Nursing

Volumn 16, Issue 3, 2012, Pages 315-322

  Hedayati, Elham ^a,b   Alinaghizadeh, Hassan ^a   Schedin, Anna ^a   Nyman, Håkan ^a   Albertsson, Maria ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; Cancer treatments; Cognitive functioning; Longitudinal study

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANXIETY; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; COGNITION; DEPRESSION; FEMALE; HUMAN; LONGITUDINAL STUDY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PROSPECTIVE STUDY; QUALITY OF LIFE; STATISTICAL MODEL; SWEDEN;

ADULT; AGED; ANXIETY; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COGNITION; DEPRESSION; FEMALE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SWEDEN;

EID: 84861348604     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2011.07.006     Document Type: Article

References (48)

1. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., Filiberti A., Flechtner H., Fleishman S.B., de Haes J.C.J.M., Kaasa S., Klee M., Osoba D., Razavi D., Rofe P.B., Schraub S., Sneeuw K., Sullivan M., Takeda F. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of National Cancer Institute 1993, 85:365-376.
2. Ahles T., Saykin A., Mcdonald B., Furstenberg C., Cole B., Hanscom B., Mulrooney T., Schwartz G., Kaufman P. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Research and Treatment 2008, 110:143-152.
3. Ahles T.A., Saykin A.J., Furstenberg C.T., Cole B., Mott L.A., Skalla K., Whedon M.B., Bivens S., Mitchell T., Greenberg E.R., Silberfarb P.M. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology 2002, 20:485-493.
4. Anderson-Hanley C., Sherman M.l., Riggs R., Agocha V.B., Compas B.E. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. Journal of the International Neuropsychological Society 2003, 9:967-982.
5. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology 1988, 56:893-897.
6. Beck A.T., Steer R.A., Brown G.K. Manual for Beck Depression Inventory-II 1996, San Antonio.
7. Bender C.M., Sereika S.M., Berga S.l., Vogel V.G., Brufsky A.M., Paraska K.K., Ryan C.M. Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology 2006, 15:422-430.
8. Bender C.M., Sereika S.M., Brufsky A.M., Ryan C.M., Vogel V.G., Rastogi P., Cohen S.M., Casillo F.E., Berga S.L. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause 2007, 14:995-998.
9. Berglund G., Bolund C., Fornander T., Rutqvist L.E., Sjoden P.O. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. European Journal of Cancer 1991, 27:1075-1081.
10. Caserta M.T., Bannon Y., Fernandez F., Giunta B., Schoenberg M.R., Tan J., Alireza M. Normal brain aging: clinical, immunological, neuropsychological, and neuroimaging features. International Review of Neurobiology 2009, 84:1-19.
11. Castellon S.A., Pa Ganz P.A. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology 2004, 26:955-969.
12. Cimprich B., Reuter-Lorenz P., Nelson J., Clark P.M., Therrien B., Normolle D., Berman M.G., Hayes D.F., Noll D.C., Peltier S., Welsh R.C. Prechemotherapy alterations in brain function in women with breast cancer. Journal of Clinical and Experimental Neuropsychology 2009, 32:324-331.
13. Collins B., Mackenzie J., Stewart A., Bielajew C., Verma S. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology 2009, 18:134-143.
14. Collins B., Mackenzie J., Stewart A., Bielajew C., Verma S. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study. Psycho-Oncology 2009, 18:811-821.
15. Correa D.D., Ahles T.A. Neurocognitive changes in cancer survivors. Cancer Journal 2008, 14:396-400.
16. Debess J., Riis J., Engebjerg M., Ewertz M. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Research and Treatment 2010, 121:91-100.
17. Downie F.P., Mar Fan H.G., Houédé-Tchen N., Yi Q., Tannock I.F. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psycho-Oncology 2006, 15:921-930.
18. Eberling J.L., Wu C., Tong-Turnbeaugh R., Jagust W.J. Estrogen- and tamoxifen-associated effects on brain structure and function. NeuroImage 2004, 21:364-371.
19. Erlanger D., Feldman D., Kutner K., Kaushik T., Kroger H., Festa J., Barth J., Freeman J., Broshek D. Development and validation of a web-based neuropsychological test protocol for sports-related return-to-play decision-making. Archives of Clinical Neuropsychology 2003, 18:293-316.
20. Erlanger D.M., Kaushik T., Broshek D., Freeman J., Feldman D., Festa J. Development and validation of a web-based screening tool for monitoring cognitive status. Journal of Head Trauma Rehabilitation 2002, 17:458-476.
21. Ernst T., Chang L., Cooray D., Salvador C., Jovicich J., Walot I., Boone K., Chlebowski R. The effects of tamoxifen and estrogen on brain metabolism in elderly women. Journal of the National Cancer Institute 2002, 94:592-597.
22. Fayers P.M., Aaronson N.K., Bjordal K., Groenvold M., Curran D., Bottomley A. The EORTC QLQ-C30 Scoring Manual 2001, European Organization for Research and Treatment of Cancer, Brussels. third ed.
23. Hedayati E., Schedin A., Alinaghizadeh H., Nyman H., Albertsson A. The effects of breast cancer diagnosis and surgery on cognitive functions. Acta Oncologica 2011, [Epub ahead of print].
24. Hermelink K., Untch M., Lux M.P., Kreienberg R., Beck T., Bauerfeind I., Munzel K. Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer 2007, 109:1905-1913.
25. Hermelink K., Henschel V., Untch M., Bauerfeind I., Lux M.P., Munzel K. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients. Cancer 2008, 113:2431-2439.
26. Hurria A., Rosen C., Hudis C., Zuckerman E., Panageas K.S., Lachs M.S., Witmer M., Van Gorp W.G., Fornier M., D'andrea G., Moasser M., Dang C., Van Poznak C., Holland J. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. Journal of the American Geriatrics Society 2006, 54:925-931.
27. Jenkins V., Shilling V., Fallowfield L., Howell A., Hutton S. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psycho-Oncology 2004, 13:61-66.
28. Jenkins V., Shilling V., Deutsch G., Bloomfield D., Morris R., Allan S., Bishop H., Hodson N., Mitra S., Sadler G., Shah E., Stein R., Whitehead S., Winstanley J. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer 2006, 94:828-834.
29. Jenkins V.A., Ambroisine L.M., Atkins L., Cuzick J., Howell A., Fallowfield L.J. Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II). The Lancet Oncology 2008, 9:953-961.
30. Littell R.C., Milliken G.A., Stroup W.W. SAS for Mixed Models 2006, SAS Publishing, New York. second ed..
31. Mehlsen M., Pedersen A.D., Jensen A.B., Zachariae R. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psycho-Oncology 2009, 18:248-257.
32. Meyers C.A., Byrne K.S., Komaki R. Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 1995, 12:231-235.
33. Minisini A., Atalay G., Bottomley A., Puglisi F., Piccart M., Biganzoli L. What is the effect of systemic anticancer treatment on cognitive function?. The Lancet Oncology 2004, 5:273-282.
34. Paganini-Hill A., Clark L. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Research and Treatment 2000, 64:165-176.
35. Quesnel C., Savard J., Ivers H. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Research and Treatment 2009, 116:113-123.
36. Raudenbush S.W., Bryk A.S. Hierarchical Linear Models 2002, Sage Publications, Thousand Oaks.
37. Schagen S.B., van Dam F.S.A., Muller M.J., Boogerd W., Lindeboom J., Bruning P.F. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999, 85:640-650.
38. Schagen S.B., Muller M.J., Boogerd W., Mellenbergh G.J., van Dam F.S.A. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute 2006, 98:1742-1745.
39. Schilder C.M., Eggens P.C., Seynaeve C., Linn S.C., Boogerd W., Gundy C.M., Beex L.V., Van Dam F.S., Schagen S.B. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncologica 2009, 48:76-85.
40. Shilling V., Jenkins V. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. European Journal of Oncology Nursing 2007, 11:6-15.
41. Shilling V., Jenkins V., Morris R., Deutsch G., Bloomfield D. The effects of adjuvant chemotherapy on cognition in women with breast cancer-preliminary results of an observational longitudinal study. The Breast 2005, 14:142-150.
42. Vardy J., Rourke S., Tannock I.F. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. Journal of Clinical Oncology 2007, 25:2455-2463.
43. Vardy J., Wefel J.S., Ahles T., Tannock I.F., Schagen S.B. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Annals of Oncology 2008, 19:623-629.
44. Vodermaier A. Breast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments. Women's Health 2009, 5:503-516.
45. Wefel J.S., Lenzi R., Theriault R., Buzdar A.U., Cruickshank S., Meyers C.A. 'Chemobrain' in breast carcinoma?. Cancer 2004, 101:466-475.
46. Wefel J.S., Lenzi R., Theriault Rl, Davis R.N., Meyers C.A. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer 2004, 100:2292-2299.
47. Wieneke M.H., Dienst E.R. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 1995, 4:61-66.
48. Zehnder A.E., Blasi S., Berres M., Spiegel R., Monsch A.U. Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease?. American Journal of Alzheimer's Disease and Other Dementias 2007, 22:416-426.